(Q50588378)

English

Ribavirin conjugated with lactosaminated poly-L-lysine: selective delivery to the liver and increased antiviral activity in mice with viral hepatitis.

scientific article published in August 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

Ribavirin conjugated with lactosaminated poly-L-lysine: selective delivery to the liver and increased antiviral activity in mice with viral hepatitis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

1 reference

based on heuristic

inferred from title

author name string

Di Stefano G

1

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

Colonna FP

2

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

Bongini A

3

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

Busi C

4

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

Mattioli A

5

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

Fiume L

6

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

language of work or name

0 references

publication date

1 August 1997

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

54

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

3

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

357-363

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

A pilot study of ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Enhanced inhibition of virus DNA synthesis in hepatocytes by trifluorothymidine coupled to asialofetuin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Hepatocyte targeting of adenine-9-beta-D-arabinofuranoside 5' -monophosphate (ara-AMP) coupled to lactosaminated albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Drug targeting in antiviral chemotherapy. A chemically stable conjugate of 9-beta-D-arabinofuranosyl-adenine 5'-monophosphate with lactosaminated albumin accomplishes a selective delivery of the drug to liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Galactosylated poly(L-lysine) as a hepatotropic carrier of 9-beta-D-arabinofuranosyladenine 5'-monophosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Carbohydrate-Specific Receptors of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin. Efficacy and minimal active dose.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

A conjugate of lactosaminated poly-L-lysine with adenine arabinoside monophosphate, administered to mice by intramuscular route, accomplishes a selective delivery of the drug to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Selective delivery to the liver of antiviral nucleoside analogs coupled to a high molecular mass lactosaminated poly-L-lysine and administered to mice by intramuscular route.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly-L-lysine. Synthesis of the carrier and pharmacological properties of the conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Effect of ribavirin on viral hepatitis in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Proteins containing reductively aminated disaccharides. Synthesis and chemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Colorimetric Method for Determination of Sugars and Related Substances

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Coupling of antiviral nucleoside analogs to lactosaminated human albumin by using the imidazolides of their phosphoric esters

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

A novel method for phosphorylation of nucleosides to 5′-nucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

A labeled 9-beta-D-arabinofuranosyladenine 5'-monophosphate having increased metabolic stability

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

The relationship between the metabolism of ribavirin and its proposed mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Organ distribution of a conjugate of adenine arabinoside monophosphate with lactosaminated albumin in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Metabolism of 5-amino-1-β-d-ribofuranosyl- imidazole-4-carboxamide and related five-membered heterocycles to 5′-triphosphates in human blood and L5178Y cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900223-2

7 January 2021

Identifiers

10.1016/S0006-2952(97)00223-2

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/9278094

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50588378&oldid=1372108895"